Hyaluronic acid supplementation for synovial fluid viscosity enhancement (HA supplementation)

Hyaluronic acid is a naturally occurring, high-molecular-weight glycosaminoglycan present in synovial fluid, where it provides viscosity, elasticity, and lubrication essential for normal joint function[2][6]. In osteoarthritis and other joint diseases, the concentration and molecular weight of synovial HA are reduced, resulting in lower viscosity, greater friction, and joint pain[4]. Exogenous hyaluronic acid (administered via intra-articular injection, a process termed viscosupplementation) aims to restore the biomechanical and lubricating properties of synovial fluid, reduce inflammation, protect cartilage, and improve joint mobility and pain[4][5][8]. These effects are mediated by HA’s unique viscoelastic and hydrating properties, its structural interactions within the extracellular matrix, and its actions on cell surface receptors (such as CD44 and RHAMM)[5][7]. Viscosupplementation is considered most effective in early to moderate osteoarthritis and is associated with a generally favorable safety profile, though clinical benefit may be limited in late-stage disease[4][8]. **Note:** The query describes neither a canonical target nor a specific molecule, but a therapeutic intervention aimed at restoring a physiological property. Hyaluronic acid itself *is* a molecular entity (glycosaminoglycan), but "synovial fluid viscosity enhancement" is not a molecule, receptor, or druggable target. The correct canonical annotation would focus on “Hyaluronic acid” as the molecule, but the phrasing given is inaccurate for structured target databases.

Other names

Synovial fluid viscosity enhancementLubrication improvement via hyaluronic acidIntra-articular hyaluronic acid injectionViscosupplementationExogenous HA supplementation

Restoration of viscous and elastic properties of synovial fluid; Reduction of joint friction by physical lubrication; Modulation of inflammatory cytokine response (e.g., suppression of IL-1β); Stimulation of endogenous HA synthesis; Protection of articular cartilage matrix